Russell Broadbent and a group comprising scientists, health professionals, lawyers, and academics, wrote to the Prime ...

Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...

Pfizer shares are moving higher on Wednesday as the sector sees volatility amid Robert F. Kennedy Jr.'s nomination as the secretary of the Department of Health and Human Services.

Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Dividend stocks are increasingly appealing for investors in 2025 due to their potential for steady income and resilience in volatile markets. As the economic landscape evolves, characterized by rising ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

The leader of the French Patriots party, Florian Philippot, sharply criticized the statement of the head of the European ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Pfizer reported better-than-expected quarterly profits on Tuesday behind cost cuts and growth in some non-Covid-related products including the blood clot drug Eliquis. Other pharmaceuticals with ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.